Uckun, Z. Et Al. 2015. The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.40, no.6 , 672-679.

Uckun, Z., Baskak, B., ÖZEL KIZIL, E. T., Ozdemir, H., ÖZGÜVEN, H., & SÜZEN, H. S., (2015). The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.40, no.6, 672-679.

Uckun, Z. Et Al. "The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.40, no.6, 672-679, 2015

Uckun, Z. Et Al. "The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.40, no.6, pp.672-679, 2015

Uckun, Z. Et Al. (2015) . "The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.40, no.6, pp.672-679.

@article{article, author={Z. Uckun Et Al. }, title={The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder}, journal={JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS}, year=2015, pages={672-679} }